A carregar...

QT/QTc safety and efficacy evaluation of teneligliptin in Indian type 2 diabetes mellitus patients: the “thorough QT/QTc” study (Q-SET study)

Background: Newer therapies, such as dipeptidyl peptidase-IV inhibitors, are increasingly being used in the treatment of type 2 diabetes mellitus (T2DM). Teneligliptin, a DPP4 inhibitor, currently commonly used as monotherapy or as add-on therapy, was generally well tolerated in patients with T2DM d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Metab Syndr Obes
Main Authors: Erande, S, Sarwardekar, S, Desai, B
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6593689/
https://ncbi.nlm.nih.gov/pubmed/31417296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S202458
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!